US Stem Cell Inc (OTCMKTS:USRM) a Florida corporation and pioneer in novel regenerative medicine offerings and physician-based stem cell treatments to animal and human patients, reported the newest publication by Chief Scientific Officer, Kristin Comella.
The buzz
US Stem stated that the trial concentrated on the implantation of SVF in subjects suffering from progressive disc disease. Subjects opted for a local tumescent liposuction procedure to eradicate almost 60 ml of fat tissue from their abdomen area. The fat was parted to separate the SVF and the cells were supplied right into the damaged discs. Subjects were monitored for as much as 6 months after treatment, observing considerable increases in flexion and decreases in pain.
Ms. Comella’s preceding paper, was introduced in the Journal of Translational Medicine’s publication of June 2016. Utilizing the same process, chronic ischemic cardiomyopathy subjects were assessed after SVF injection and can walk over 80 additional meters 3 months to 6 months after cure.
At U.S. Stem, the company is dedicated to new technological improvements and treatments that provide a renewed sense of confidence to subjects with degenerative ailments. SVF is the recent treatment in a long line of positive treatments the company has pioneered. Ms. Comella intends to keep working with SVF, which has unfailingly repeated its success and robust safety profile in curing patients.
US Stem is a growing enterprise in the cellular therapy/ regenerative medicine industry. They are focused on the development, commercialization and discovery of cell based treatments that prevent, cure or treat disease by replacing and repairing aged or damaged tissue, organs and cells, and reinstating their normal function.
The company considers that the field of regenerative medicine and cellular therapeutics will play a major role in positively transforming the natural history of ailments, ultimately, they contend, reducing patient burdens, and decreasing the related economic impact disease forces upon modern society.
